Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP30565.RAYhaZyDAmoRQi2MN9WlgsdFpyZVnfI6Lht4GQ91kk0yc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP30565.RAYhaZyDAmoRQi2MN9WlgsdFpyZVnfI6Lht4GQ91kk0yc130_assertion type Assertion NP30565.RAYhaZyDAmoRQi2MN9WlgsdFpyZVnfI6Lht4GQ91kk0yc130_head.
- NP30565.RAYhaZyDAmoRQi2MN9WlgsdFpyZVnfI6Lht4GQ91kk0yc130_assertion description "[Utilization of fluorescence in situ hybridization with cytokeratin discriminators in TOP2A assessment of chemotherapy-treated patients with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP30565.RAYhaZyDAmoRQi2MN9WlgsdFpyZVnfI6Lht4GQ91kk0yc130_provenance.
- NP30565.RAYhaZyDAmoRQi2MN9WlgsdFpyZVnfI6Lht4GQ91kk0yc130_assertion evidence source_evidence_curated NP30565.RAYhaZyDAmoRQi2MN9WlgsdFpyZVnfI6Lht4GQ91kk0yc130_provenance.
- NP30565.RAYhaZyDAmoRQi2MN9WlgsdFpyZVnfI6Lht4GQ91kk0yc130_assertion SIO_000772 22204715 NP30565.RAYhaZyDAmoRQi2MN9WlgsdFpyZVnfI6Lht4GQ91kk0yc130_provenance.
- NP30565.RAYhaZyDAmoRQi2MN9WlgsdFpyZVnfI6Lht4GQ91kk0yc130_assertion wasDerivedFrom ctd_human-2016 NP30565.RAYhaZyDAmoRQi2MN9WlgsdFpyZVnfI6Lht4GQ91kk0yc130_provenance.
- NP30565.RAYhaZyDAmoRQi2MN9WlgsdFpyZVnfI6Lht4GQ91kk0yc130_assertion wasGeneratedBy ECO_0000218 NP30565.RAYhaZyDAmoRQi2MN9WlgsdFpyZVnfI6Lht4GQ91kk0yc130_provenance.